 |
 |
 |
| 24小時(shí)熱門(mén)版塊排行榜 |
- >論壇更新日志 (679)
- >考研 (69)
- >導(dǎo)師招生 (29)
- >基金申請(qǐng) (11)
- >蟲(chóng)友互識(shí) (8)
- >休閑灌水 (8)
- >碩博家園 (7)
- >教師之家 (2)
- >博后之家 (1)
- >微米和納米 (1)
- >考博 (1)
- >找工作 (1)
- >文獻(xiàn)求助 (1)
- >公派出國(guó) (1)
 |
 |
 |
||
 |
 |
 |
 |
 |
| 2 | 1/1 | 返回列表 |
| 查看: 377 | 回復(fù): 1 | |||
| 本帖產(chǎn)生 1 個(gè) 翻譯EPI ，點(diǎn)擊這里進(jìn)行查看 | |||
籃球少年新蟲(chóng) (小有名氣)
|
[求助]
求人翻譯 ~~~ 謝謝�。�！
|
||
|
However, the use of copper(II) salts as anticancer drugs presents some drawbacks, which are mainly related to their toxicity and relatively poor bioavailability. To overcome these limitations, copper(II) complexes of multidentate chelate ligands have been evaluated in recent years as alternatives to simple copper salts. In this paper, we report the synthesis of several new copper(II) complexes of various amino acid-derived Schiff base ligands. It is well known that 5-Fluorouracil (5-FU) remains the most commonly used anticancer drug for the treatment of solid tumors, although objective response rates are as low as 20%. Biological activity data showed that the complexes obtained in this study were more cytotoxic than 5-FU against tumor cell lines. 5.jpg |
回復(fù)此樓» 猜你喜歡
本人考085602 化學(xué)工程 專(zhuān)碩
已經(jīng)有23人回復(fù)
-
求調(diào)劑院校信息
已經(jīng)有4人回復(fù)
-
085600材料與化工306
已經(jīng)有4人回復(fù)
-
286求調(diào)劑
已經(jīng)有10人回復(fù)
-
328求調(diào)劑，英語(yǔ)六級(jí)551，有科研經(jīng)歷
已經(jīng)有9人回復(fù)
-
一志愿北京化工大學(xué)070300 學(xué)碩336求調(diào)劑
已經(jīng)有4人回復(fù)
-
286分人工智能專(zhuān)業(yè)請(qǐng)求調(diào)劑愿意跨考！
已經(jīng)有8人回復(fù)
-
資源與環(huán)境 調(diào)劑申請(qǐng)(333分)
已經(jīng)有5人回復(fù)
-
280求調(diào)劑
已經(jīng)有12人回復(fù)
-
269專(zhuān)碩求調(diào)劑
已經(jīng)有5人回復(fù)
ssssllllnnnn 
至尊木蟲(chóng) (知名作家)
Translator and Proofreader
- 翻譯EPI: 1690
- 應(yīng)助: 452 (碩士)
- 金幣: 31580.9
- 紅花: 100
- 帖子: 7681
- 在線(xiàn): 19966.6小時(shí)
- 蟲(chóng)號(hào): 3328089
- 注冊(cè): 2014-07-17
- 專(zhuān)業(yè): 腫瘤發(fā)生
【答案】應(yīng)助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
籃球少年: 金幣+12, 翻譯EPI+1, ★★★★★最佳答案, 很不錯(cuò) 2014-11-20 17:44:30
籃球少年: 金幣+12, 翻譯EPI+1, ★★★★★最佳答案, 很不錯(cuò) 2014-11-20 17:44:30
| 然而，使用銅（II）鹽作為抗腫瘤藥物存在一些缺點(diǎn)，主要與它們的毒性和生物利用度比較差有關(guān)。為克服這些限制，近年來(lái)，作為簡(jiǎn)單銅鹽的替代物，已經(jīng)對(duì)多齒螯合配位體銅（II）配合物進(jìn)行了評(píng)價(jià)。在本文中，我們報(bào)道的各種氨基酸衍生的席夫堿配體的幾種新銅（II）配合物的合成。眾所周知，5-氟尿嘧啶（5-FU）仍然是用于治療實(shí)體瘤的最常用抗癌藥物，雖然客觀應(yīng)答率低達(dá)20％。生物活性數(shù)據(jù)表明，在本研究中得到的復(fù)合物在抗腫瘤細(xì)胞系中比5-FU的細(xì)胞毒性更大。 |
2樓2014-11-20 13:37:09
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 籃球少年 的主題更新
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研]
 一志愿東華大學(xué)控制學(xué)碩320求調(diào)劑
+3
|
Grand777 2026-03-21 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 考研化學(xué)學(xué)碩調(diào)劑，一志愿985 +5 | 張vvvv 2026-03-15 | 7/350 |
|
|
[考研] 求調(diào)劑 +4 | 要好好無(wú)聊 2026-03-21 | 4/200 |
|
|
|
[考研] 求調(diào)劑 +3 | 13341 2026-03-20 | 3/150 |
|
|
|
[考研] 296求調(diào)劑 +4 | www_q 2026-03-20 | 4/200 |
|
|
|
[考研] 266求調(diào)劑 +3 | 哇呼哼呼哼 2026-03-20 | 3/150 |
|
|
|
[考研] 求調(diào)劑 +6 | Mqqqqqq 2026-03-19 | 6/300 |
|
|
|
[考研] 08工科 320總分 求調(diào)劑 +6 | 梨花珞晚風(fēng) 2026-03-17 | 6/300 |
|
|
|
[考研] 一志愿天津大學(xué)化學(xué)工藝專(zhuān)業(yè)（081702）315分求調(diào)劑 +12 | yangfz 2026-03-17 | 12/600 |
|
|
|
[考研] 303求調(diào)劑 +5 | 睿08 2026-03-17 | 7/350 |
|
|
|
[考研] 299求調(diào)劑 +6 | △小透明* 2026-03-17 | 6/300 |
|
|
|
[考研]
271材料工程求調(diào)劑
+8
|
.6lL 2026-03-18 | 8/400 |
|
|
|
[考研] 22408 344分 求調(diào)劑 一志愿 華電計(jì)算機(jī)技術(shù) +4 | solanXXX 2026-03-20 | 4/200 |
|
|
|
[考研] 295求調(diào)劑 +4 | 一志愿京區(qū)211 2026-03-18 | 6/300 |
|
|
|
[考研] 304求調(diào)劑 +7 | 司空. 2026-03-18 | 7/350 |
|
|
|
[考研] 求調(diào)劑 +3 | eation27 2026-03-20 | 3/150 |
|
|
|
[考博] 招收博士1-2人 +3 | QGZDSYS 2026-03-18 | 3/150 |
|
|
|
[考研] 085601求調(diào)劑 +4 | Du.11 2026-03-16 | 4/200 |
|
|
|
[考研] 材料工程專(zhuān)碩274一志愿211求調(diào)劑 +6 | 薛云鵬 2026-03-15 | 6/300 |
|
|
|
[考研]
11408 一志愿西電，277分求調(diào)劑
+3
|
zhouzhen654 2026-03-16 | 3/150 |
|